WO2010039465A2 - Methods of measuring human body frequencies or harmonics and treating conditions based on the resonance phenomenon between a product and a human body's frequencies or harmonics - Google Patents

Methods of measuring human body frequencies or harmonics and treating conditions based on the resonance phenomenon between a product and a human body's frequencies or harmonics Download PDF

Info

Publication number
WO2010039465A2
WO2010039465A2 PCT/US2009/057570 US2009057570W WO2010039465A2 WO 2010039465 A2 WO2010039465 A2 WO 2010039465A2 US 2009057570 W US2009057570 W US 2009057570W WO 2010039465 A2 WO2010039465 A2 WO 2010039465A2
Authority
WO
WIPO (PCT)
Prior art keywords
condition
emitted
frequency
human
skin
Prior art date
Application number
PCT/US2009/057570
Other languages
French (fr)
Other versions
WO2010039465A3 (en
Inventor
Kenneth D. Marenus
Geoffrey Hawkins
Barbara A. Wolf
Vasile Ionita-Manzatu
Jack Lombardi
Lavinia C. Popescu
Glen Rein
Original Assignee
Elc Management Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US9926208P priority Critical
Priority to US61/099,262 priority
Application filed by Elc Management Llc filed Critical Elc Management Llc
Publication of WO2010039465A2 publication Critical patent/WO2010039465A2/en
Publication of WO2010039465A3 publication Critical patent/WO2010039465A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof

Abstract

A method for measuring in real-time the frequency and the power of an electromagnetic ("EM") field emitted by a human body for different body conditions, the resonance phenomenon between the EM fields emitted by various products or electronic devices and the EM field emitted by a human body, and the signals emitted by active materials, waters, topical products, etc. A first real time spectrum analyzer is connected to a broad frequency range antenna placed in contact with the skin, electromagnetic fields emitted by a particular condition of the subject human body are measured to reveal peaks of power, and a second narrow frequency antenna is used to measure the peak more accurately. A product is applied to the condition, and a second measurement of the EM field is taken. The measurements will be particularly useful to identify skin and body deficiencies. The methods will facilitate development of treatments to mitigate/remediate skin/body deficiencies through application of topical cosmetics or pharmaceutical products or by the use of a device (digitalized cosmetics) that emits specially selected electromagnetic signals/frequencies or their harmonics to match or interfere with the electromagnetic frequencies and their harmonics emitted by the afflicted parts of the body.

Description

METHODS OF MEASURING HUMAN BODY FREQUENCIES OR HARMONICS AND TREATING CONDITIONS BASED ON THE RESONANCE PHENOMENON BETWEEN A PRODUCT AND A HUMAN BODY'S FREQUENCIES OR
HARMONICS
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
The present invention relates to the field of skin treatment with cosmetic, dermatologic and medical products and methods. In particular the invention provides novel methods of measuring and treating human body conditions including but not limited to conditions of skin, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetics, musculoskeletal, mood, tinnitus, etc.
BACKGROUND OF THE INVENTION
A number of authors emphasize that the human body generates electromagnetic fields and mechanical vibrations with different frequencies. For example, V. S. Troitskii et al. "Intrinsic microwave radiation from the human body" Vol. 24, Number 1, January 1981, Radiophysics and Quantum Electronics, discloses measurement of intrinsic radiation from the human body, radiation which is due to thermal motion of electrons in biological tissue. It is said that the intensity of this radiation is proportional to the temperature of the region of the body from which it originates. The frequencies measured by this radiometry method are between 1 GHz and 10 GHz. Y. Feldman et al., Phys. Rev. Lett. 100, 128102, 2008, discloses that the sweat glands in human skin act like an array of tiny antennas that pick up radiation of specific frequencies, around 90 GHz. D. B. Rendon et al., Mapping the Human Body for Vibrations using an Accelerometer, Conf. Proc. IEEE Eng Med Biol Soc. 2007; 1 :1671-1674, discloses the use of an accelerometer to measure the vibration of the neck and thorax. Three different frequencies: breathing signal 0.1-0.5Hz; heart signal 0.5-3Hz and snoring signal 3-500Hz were said to be found. T. G. Wang et al., Resonance frequency in patellar tendon, Scand J Med Sci Sports, 2007; 17; 535, describes a method based on a vibrator which was attached to the tibia of 10 healthy subjects in order to measure the resonance frequency of the patellar tendon. A mean resonance frequency at 22.5; 23.0 and 24±0.8MHz was produced in the right patellar tendon when the joint was at 0°; 60° and 90° of flexion. C. Smith, Straws in the Wind, J. of Alternative and Complementary Medicine, measured the frequencies of human body tissue in acupuncture points. L. Turin, A Spectroscopic Mechanism for Primary Olfactory Reception, Chemical Senses, 1996, Vol. 21/6;773-791 , describes a novel theory of primary olfactory reception. The author proposes that olfactory receptors respond not to the shape of the molecules but to their vibrations. He recorded the wavenumbers for a variety of scents to be between 0-4,000cm-1. L. Turin, The Emperor of Scent describes the Vibrational Theory of a scent. U.S. Pat. No. 6,033,531 discloses a spectral catalyst that is said to duplicate the electromagnetic energy spectral pattern of a physical catalyst and when applied to a reaction system transfers a quanta of energy in the form of electromagnetic energy to control and/or promote the reaction system.
There are not known in the art any methods for measuring in real time (typically
48,000 spectral acquisitions/sec) the frequencies of an electromagnetic field emitted by the human body as a whole. There are not known in the art any methods for treating different body conditions, such as, for example, skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetic, musculoskeletal, mood, tinnitus, etc., based on the resonance phenomenon between the frequencies emitted by the products and the human body frequencies for different body conditions.
There are not known in the art any methods to measure the frequencies and the phase of an electromagnetic field emitted by allergens from fragrances, essential oils, other plant extracts and ingredients or pharmaceutical actives and match such a signal to that emitted by the human body.
There are not known in the art any methods of interfering with the electromagnetic signal emitted by allergens that match the frequency of the human body through counter- phase emitting products.
Accordingly, there is a need for improved methods of measuring in real time the frequency or frequencies of electromagnetic fields emitted by and mechanical vibrations generated by the human body as a whole and/or specific human body tissue. There is also a need for using the information obtained from such measurements to treat different body conditions, such as, for example, skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetic, musculoskeletal, mood, tinnitus, etc., based on the resonance phenomenon between the frequencies emitted by the products and the human body frequencies for different body conditions. BRIEF SUMMARY OF THE INVENTION
It is an object of the invention to provide methods of measuring and characterizing the frequencies, phase and intensity (or amplitude) of the electromagnetic field emitted by a human body for different body conditions: skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetic, musculoskeletal, mood, tinnitus, etc.
It is another object of the invention to provide methods of treating different body conditions: skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, mood, tinnitus, etc., based on the resonance phenomenon between the frequencies emitted by the products and the human body frequencies for different body conditions.
It is another object of the invention to measure the frequencies phase and intensity (or amplitude) of electromagnetic fields emitted by allergens from fragrances, essential oils, other plant extracts, and ingredients or pharmaceutical actives.
Another object of the invention is to provide methods of interfering with the electromagnetic signal(s) emitted by allergens through counter-phase emitting products.
Accordingly, disclosed and claimed herein are methods of measuring frequencies of electromagnetic fields emitted by the human body, and treatments based on those measured frequencies.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1a is a schematic illustration of broad band measurement of frequencies emitted by skin; and Fig. 1 b is a schematic illustration of narrow band measurement of frequencies emitted by skin.
DETAILED DESCRIPTION OF THE INVENTION
Accordingly, the inventors have conducted research leading to the discovery of: a) a method for measuring in real-time the frequency and the power of an electromagnetic ("EM") field emitted by a human body for different body conditions; b) a method for measuring in real-time the resonance phenomenon between the EM fields emitted by various products or electronic devices and the EM field emitted by a human body; c) a method for measuring the frequency of EM signals emitted by active materials, waters, topical products, etc.; and d) a method for treating a particular condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood.
In this application, the term "product" includes but is not limited to any cosmetic or pharmaceutical topical cream, gel, lotion, aqueous solution, solid powder or stick, and/or any electronic device which broadcasts EM or mechanical waves, etc. The term "frequencies" when used with respect to human body frequencies and/or product frequencies also refers to any harmonics of or related to these frequencies.
The inventions are detailed in the following examples, which are illustrative and not meant to be all-inclusive. Any device or antennae capable of making the appropriate measurements of transient EM signals in real time would suffice.
a) Method for measuring in real-time the frequency and the power of an electromagnetic field emitted by a human body for different body conditions:
The method for measuring in real-time the frequency and the power of an EM field emitted by a human body for different body conditions was conducted using a real-time spectrum analyzer (model RSA 61 14A manufactured by Tektronix Inc, Beaverton, OR. The spectrum analyzer is capable of reading transient EM signals at a rate of 48,000 spectrum measurements per second. A linear, broad range antenna or any antennae capable of capturing the range of frequencies operating in the 20 MHz to 900 MHz range was coupled to the instrument for preliminary scanning of EM signals emitted by a subject's human body. The antenna was placed in direct contact with the skin of the subject. Strong EM signals occurred at 75.01 MHz and 91 MHz. To increase the selectivity and gain, two quarter-wave wire wound antennas were built for these particular EM frequencies: a first at 3.3 meters/4=0.825M length, with 5 windings for the 91 MHz antennae; and a second at 4.0 meters/4=1.0 meters length, with 4 windings for the 75.01 MHz antennae. Each antenna was insulated with PVC. These coils, respectively, were placed in direct contact with the skin to receive or 'pick-up' the EM signals emitted by the human body. The spectrum, the frequencies and the units of power (amplitude) of the EM signals are measured by and displayed on the screen of the spectrum analyzer. While quarter-wave wire wound antennas were used, any antennae tuned to recieve these frequencies can be used.
EXAMPLE 1
Using the experimental set-up described above, measurements were taken for the following conditions:
1) Healthy People: Five relatively younger people (22-25 years) and six relatively older people (54-60 years) were used as subjects. The frequencies and the amplitudes (signal power) at 75.01 MHz were measured on the right cheek and left cheek of each subject. The results are the following:
Table 1 : Younger people
Figure imgf000006_0001
Table 2: Older people
Figure imgf000006_0002
2) Diabetic People:
Healthy skin frequency was obtained by taking an average of 10 healthy test subjects. Diabetic skin measurements were obtained by taking an average of 5 type Il diabetic individuals. The average intensity for healthy people was taken from the younger-older age group study. Side peak frequencies were detected at +/- 1-2KHz from the main (75MHz) peak when measurements were taken from the diabetic subjects. Because side peak frequencies of this type were detected only from the diabetic subjects, the inventors believe that the extra side peak frequencies indicate that diseased skin will also exhibit frequency information different from that of healthy subjects. In this case the skin of the diseased subjects exhibited extra frequencies (the side peaks). The inventors further believe that cancelling the frequencies with a treatment regimen may relieve the symptoms and/or mitigate or cure the disease.
Healthy: Avg 10 test subjects Peak = 795 fempto Watts
Type Il Diabetics:
Avg 5 test subjects Main Peak = 550.6 fempto Watts Avg 5 test subjects Side Peaks = 413.8 fempto Watts
b) Method for measuring in real-time the resonance phenomenon between the electromagnetic fields emitted by the products or electronic devices and the human body:
The method for measuring in real-time the resonance phenomenon between the EM fields emitted by the human body and the EM fields emitted by a product (e.g., a cosmetic cream) topically applied and/or an electronic device acting on the human body utilizes the data obtained from the method and instruments described in the foregoing paragraph. Using the method and instruments described in section a) above, a first measurement is taken of frequency and amplitude (power) of EM signals emitted by a human body, without any topical product applied to the skin, or without broadcasting any EM waves directed to the skin from an electronic device. These values represent the "Control" or the signal from the body alone.
Next, a topical product is applied to the skin, or EM waves are broadcast from an electronic device to the skin and the frequency and amplitude (power) of EM signals emitted by the subject human body are measured, again using the method and instruments described above. If the amplitude of EM signal measured (body plus product) is greater than the Control value, the topical product applied to the skin, or the electronic device directed at the skin, respectively, oscillate in phase with the EM signals emitted by the human body and an energetic resonant transfer occurs between the product or device and human body. If on the other hand, the amplitude of EM signal measured (body plus product) is smaller than the Control value, the topical product applied to the skin, or the electronic device directed at the skin, respectively, oscillate out of phase with the EM signal emitted by the human body but with a smaller amplitude. This is because the amplitude of the signal from a product is less than the amplitude of the signal from the body, and the difference is less than the signal from the body alone. Accordingly, it appears that a partial energetic transfer between product and human body has occurred. If the amplitude of EM signal is zero, the topical product applied to the skin, or the electronic device used, respectively, oscillate in anti-phase (the two signals are 180 degrees out of phase) with EM signals emitted by the human body with exactly the identical amplitude and the human body emitted signal is cancelled.
EXAMPLE 2
Using the experimental set-up described above, measurements were taken for the following conditions:
1) Topical products applied to the skin:
Five relatively younger people (22-25 years) and six relatively older people (54-60 years) were used as subjects. The amplitude (signal power) at a frequency of 75.01 MHz was measured on the right cheek or left cheek of each subject, once as a control before application of the cream, and again after application of the cream. The results are the followings:
CREAM A (skin moisturizing cream):
Table 3: Cream A - Younger people
Figure imgf000008_0001
Figure imgf000009_0001
Table 4: Cream A - Older people
Figure imgf000009_0002
CREAM B (skin moisturizing cream):
Table 5: Cream B - Younger people
Figure imgf000009_0003
Table 6: Cream B - Older people
Figure imgf000009_0004
Figure imgf000010_0001
Cream A appears to increase the energy of EM signal emitted by older people at 75.01 MHz. Cream B appears to significantly decrease the energy of EM signal emitted by older people at 75MHz. It is believed that young skin may exhibit an optimal human frequency signal. A parallel is commonly seen in moisture measurements in young skin versus older skin (moisturized versus dry skin) where young skin already has "maximized" optimized moisture content and, in healthy subjects, cannot be significantly increased. Also, to look at the effect of ingredient "X" on moisture, the control base should not be moisturizing or the effect of ingredient "X" will be swamped by the effect of the base. With respect to EM signals emitted by the body, it is believed that similar biological processes may be at work in impeding the ability to influence the body frequency signal of young skin with cosmetic products, i.e., the skin of young subjects already has "maximized" optimized EM emissions. Based on these observations, products can be designed that are specific for younger or older people based on a frequency/phase relationship between the product and the body. It is also believed that the technology will help younger people by preventing or at least delaying the onset of disease.
EXAMPLE 3
1) Measurement of EM waves broadcast to the skin from electronic devices:
Three types of recordings previously shown by Dr. Dan Levitin, McGiII University, Montreal, Department of Psychology to produce happy, peaceful and scary moods were exposed to test subjects. Music was played through ordinary stereo speakers at a comfortable decibel level satisfactory to all subjects and similar to that used when listening to music at home. Subjects were not isolated from other sounds. A coil as described in section a) above was placed over the left wrist of each of five healthy subjects (25-59years) to obtain the intensity of EM signals emitted by the subjects of the main peak at 75MHz as well as those of peaks on either side of the main peak. At least three measurements were taken before and during listening to musical recordings to obtain statistical data. The data below represents the average peak values at 75Mhz before and after listening to different types of music:
Table 7: EM waves broadcast to the skin from electronic devices
Before Happy Peaceful Scary
Subject 1 42fW 42fW 57fW
Subject 2 281fW 286fW 215fW 321fW
Subject 3 48fW 48fW 19fW 25fW
Subject 4 492fW 363fW 469fW 301fW
Subject 5 336fW 491fW 331fW 235fW
Note: fW = fempto Watts
60% of all subjects showed a decrease in signal strength after listening to scary music. A decrease in signal strength was noted by 75% of the test subjects after listening to peaceful music.
c) Method for measuring the frequency of emitted electromagnetic signal by active materials, waters, topical products, etc.:
In order to measure the frequencies of electromagnetic signals emitted by different substances, a BT3 Frequency Monitor System manufactured by Infinity Resources, Cheney, WA, was used. The BT3 system has a sensor which can be used to measure the frequency of any substance between 20 Hz and 1.3 GHz. A quantity of a substance weighing 10 grams was placed in a glass jar 2 cm in diameter and 5.5 cm high. An antenna was provided in contact with the glass jar containing the sample and was adapted to receive any frequency emitted by the sample into the reception bands of the BT3 sensor. The antenna is comprised of a 0.5 mm diameter copper wire with 5 windings. The glass jar which contains the sample is placed over the BT-3S sensor. The entire set-up is placed into a Faraday cage to shield it from any external EM fields. The frequencies are measured as follows:
- Measure the frequency "f1" of EM signal in the absence of the sample
- Measure the frequency "f2" of EM signal in the presence of the sample
- Calculatethe real frequency "f : f = f2 — f 1 EXAMPLE 4
Using the experimental set-up described above, measurements were taken in the absence of the samples for a baseline frequency "f1" and in the presence of the samples "f2". The baseline frequency f1 read on the frequency meter screen is 8MHz. The following samples were measured: Deionized (Dl) water, I-Water, S-Water; 10% Argireline Solution in Dl water, 10% Soluble Collagen in Dl water, Body Booster and 5% Ascorbic acid in Dl water. The results are shown in Table 8.
Table 8:
The sample f1 (MHz) /2 (MHz) f (MHz) = f2 - f1
Dl-Water 8 229.7 221.7
I-Water 8 131.34 123.34
S-Water 8 150.2 142.2
10% Argireline in Dl 8 205.46 197.46
10% Collagen in Dl 8 208.47 200.47
Body Booster 8 61.4 53.4
5% Ascorbic acid id Dl 8 83 77
Of the samples tested, only ascorbic acid appears to oscillate near the human body frequency of 75MHz. Of the materials tested, ascorbic acid is also known to be the most effective at increasing collagen synthesis, etc. Accordingly, the results above appear to support the resonant energy transfer concept. The method should theoretically allow determination of other compounds which are resonant with the human body. Therefore it appears that this method can be used to screen unknown compounds for efficacy.
The method described above demonstrates the proof of principle. It is believed that even more accurate measurements can be obtained using a spectrum analyzer. The methods disclosed using state-of-the art spectrum analyzers offers several unique advantages. They allow real-time measurements and are capable of measuring fluctuations in the intensity of the EM fields. They allow quantitative measurements at discrete frequencies and are highly sensitive measuring relatively weak fields on the order of fempto watts. Accordingly, they allow measurement of EM fields emitted by a human body for different body conditions: skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, mood, tinnitus, etc. This will permit the generation of new products for treating different body conditions: skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetic, musculoskeletal, mood, tinnitus, etc., based on the resonance phenomenon between the frequencies emitted by the products and the human body frequencies for different body conditions. They will also be useful as a tool in developing allergen free products, preservative-free cosmetic/pharmaceutical products and digitized products that impact musculoskeletal or auditory performance. They will be useful in developing digitized cosmetics/pharmaceuticals: electronic chips/devices that broadcast electromagnetic waves with the frequency which match the frequency of human body in different body conditions: skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetic, mood, etc., based on the resonance phenomenon between the frequencies emitted by the products and the human body frequencies for different body conditions; as well as digitized fragrance (non-molecular scent): capture, digitize and replaying the molecular vibration of a scent. As used herein, the term "capture" means measuring EM fields using the method previously described in this application. The term "digitize" means using a signal generator to reproduce the frequencies of a fragrance. The term "replay" means broadcasting the generated frequencies as a signal using a standard coil or other devices to generate an EM field. For example, a Helmholtz coil or ceramic crystals could be used to replay the signal.
The methods disclosed will be particularly useful to measure and identify skin and body deficiencies by determining the emitted electromagnetic field frequencies and their harmonics in real time. The methods will facilitate the development of treatments to mitigate/remediate these skin/body deficiencies through application of topical cosmetics or pharmaceutical products or by the use of a device (digitalized cosmetics) that emits specially selected electromagnetic signals/frequencies or their harmonics to match or interfere with the electromagnetic frequencies and their harmonics emitted by the afflicted parts of the body. It is believed that the methods will permit the generation of a fragrance without the use of chemicals through the use of EM field signals that match those emitted by fragrance components or their harmonic EM signals. The measurement methods will permit the development of treatments that interfere with the body's allergenic response to chemicals or biologicals by generating electromagnetic signals to interfere with those emitted by the chemical/biological. The methods will lead to improvement of the performance of the skin, respiratory, circulatory, neurological, gastrointestinal, musculoskeletal, immunologic, auditory, psychology, or general body medical systems by using topical cosmetics or pharmaceuticals or devices that emit specially designed electromagnetic frequency signals that match or interfere with the electromagnetic signals or their frequencies emitted by the body (see, for example, Table 8, the data for 5% ascorbic acid). It is believed that the methods will lead to improvement of the appearance of the skin with regard to lines and wrinkles, coloration or discoloration, dark circles, scars, barrier, elasticity, firmness, etc. by using topical cosmetics or pharmaceuticals or devices that emit selected electromagnetic frequency signals that match or interfere with the electromagnetic signals or their frequencies emitted by the body (see, for example, Table 8, the data for 5% ascorbic acid). It is believed that the methods will lead to the discovery of frequencies and or harmonics that can be generated to raise or lower entropy or enthalpy of body chemistry, enzyme activity, mechanical or electrical systems in the direction of favorable response. This includes but is not limited to Krebs cycle, blood oxygenation, glycation, wound healing, collagen and keratin production, ATP/ADP cycle and other body bio-electro-mechanical or bio-chemical activity. The methods disclosed herein may ultimately lead to the development and manufacture of cosmetic/pharmaceutical products and/or electronic devices that emit electromagnetic fields adapted to treat different body conditions: skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, diabetic, mood, etc. It is also believed that the methods may also lead to the development and manufacture of allergy free digital fragrances.
d) Method for treating a particular condition of a human subject:
A method is proposed for treating a particular condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood. The method comprises the steps of measuring in real-time the frequency and the power of an EM field emitted by the condition, selecting a cosmetic product, a pharmaceutical product or an electronic device that emits EM fields that match the frequency of EM fields emitted by the condition, and placing the cosmetic product, the pharmaceutical product or the electronic device on or sufficiently proximal to the condition, such that the EM fields emitted by the cosmetic product, the pharmaceutical product or the electronic device effectively treat the condition. Alternatively, the method comprises the steps of measuring in real-time the frequency and the power of an EM field emitted by the condition, selecting a cosmetic product, a pharmaceutical product or an electronic device that emits EM fields in a frequency, phase and amplitude suitable for treating the condition; and placing the cosmetic product, the pharmaceutical product or the electronic device on or sufficiently proximal to the condition, such that the EM fields emitted by the cosmetic product, the pharmaceutical product or the electronic device effectively treat the condition.
Because intensity of an emitted frequency drops as the square of the distance, it is advantageous to measure the frequency emitted by a condition as close as possible to the source i.e. the skin or another part of the body
When transmitting a signal to the body from an EM treatment source, the source intensity obeys the same physical principle of the inverse square law. Small intensity signals in the range of picowatts or femptowatts would be better placed directly on the body. Large intensity signals, e.g., larger picowatts to watts (or more), can directed to the targeted condition from relatively larger distances (several feet or more) as long as the intensity on or near the target is large enough to be capable of interacting with the body frequency intensity to achieve the desired results. Accordingly, the source of the EM treatment fields can be placed on the condition, e.g., by applying directly to a surface having a condition a lotion that emits EM fields suitable for treating the condition. Alternatively, the source of the EM fields can be placed at a distance from the condition, e.g., an electronic device that emits EM fields suitable for treating the condition can be placed at a pre-selected distance from the portion of the body that exhibits the condition.
To create a suitable treatment source, e.g., a lotion or a device, the measurement methods disclosed above may be used to identify existing sources that emit EM fields suitable for treating a condition. Alternatively, existing products, raw materials or compounds can be combined to create a source that emits an EM field precisely suited to treat a particular condition. Products, for example, topicals or devices, exhibiting new EM frequency fields can be made by mixing, or multiplying, two or more oscillating waveforms (i.e., heterodyning). Fundamental frequencies and heterodyne beat frequencies can simultaneously co-exist if they interact through any method of coupling including but not limited to EM wave interaction. If, for example, two fundamental frequency sources consisting of a 25Mhz source and a 50Mhz source interact, one resultant interaction frequency would be 75MHz. Applying this principle to the present method, products, raw materials or compounds with known frequencies can be combined to yield EM sources that emit frequencies that, for example, match human body frequencies. In this example the frequency desired is 75Mhz and the two separate materials have 25Mhz and 50Mhz frequencies. When these two materials are combined one resultant heterodyned frequency would be 75Mhz. This material can then be directed to a condition treatable with a frequency of 75Mhz.
It is understood that various modifications and changes in the specific form and construction of the various parts can be made without departing from the scope of the following claims.

Claims

What is claimed is:
1. A method for treating a particular condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood, the method comprising the steps of: measuring in real-time the frequency and the power of an EM field emitted by the condition; selecting a cosmetic product, a pharmaceutical product or an electronic device that emits EM fields that match the frequency of EM fields emitted by the condition; and placing the cosmetic product, the pharmaceutical product or the electronic device on or sufficiently proximal to the condition, such that the EM fields emitted by the cosmetic product, the pharmaceutical product or the electronic device effectively treat the condition.
2. A method for treating a particular condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood, the method comprising the steps of: measuring in real-time the frequency and the power of an EM field emitted by the condition; selecting a cosmetic product, a pharmaceutical product or an electronic device that emits EM fields in a frequency, phase and amplitude suitable for treating the condition; and placing the cosmetic product, the pharmaceutical product or the electronic device on or sufficiently proximal to the condition, such that the EM fields emitted by the cosmetic product, the pharmaceutical product or the electronic device effectively treat the condition.
3. A method for measuring in real-time the frequency and the power of an electromagnetic field emitted by a subject human body for different body conditions, the method comprising the steps of: connecting a first real time spectrum analyzer capable of reading transient electromagnetic signals to a broad frequency range antenna; placing the broad frequency range antenna in contact with an area of skin of the subject human body; measuring the frequencies of electromagnetic fields emitted by the area of skin; analyzing the frequencies measured to select at least one narrow frequency range in which strong electromagnetic signals occur; replacing the broad frequency range antenna with a selectively tuned antenna for the selected narrow frequency band and connecting the selectively tuned antenna to the spectrum analyzer; placing the narrow frequency range antenna in contact with the area of skin of the subject human body; and recording the frequency, phase and amplitude of electromagnetic fields emitted by the area of skin of the subject human body.
4. A method for measuring in real-time the resonance phenomenon between the EM fields emitted by a condition of a subject human body and the EM fields emitted by a topically applied product acting on the condition of the subject human body comprising the steps of: taking a first measurement in accordance with the method of claim 1 in real-time of the frequency, phase and the amplitude of an electromagnetic field emitted by a condition of a subject human body in the absence of any product applied to the condition of the subject; applying a product to the condition of the subject; taking a second measurement in accordance with the method of claim 1 of the frequency, phase and amplitude of EM signals emitted by the condition of the subject; and determining if the amplitude of EM signal in the second measurement is greater than, less than or equal to the amplitude of the EM signal in the first measurement.
5. A method for measuring in real-time the resonance phenomenon between the EM fields emitted by a condition of a subject human body after EM waves are directed to the skin from an electronic device comprising the steps of: taking a first measurement in accordance with the method of claim 3 in real-time of the frequency, phase and the power of an electromagnetic field emitted by a condition of a subject human body prior to directing EM waves from an electronic device to the condition; broadcasting EM waves from an electronic device onto a treatment area of the condition; taking a second measurement in accordance with the method of claim 1 of the frequency, phase and amplitude (power) of EM signals emitted by the condition; and determining if the amplitude of EM signal in the second measurement is greater than, less than or equal to the amplitude of the EM signal in the first measurement.
6. A method for measuring frequencies of electromagnetic signals emitted by a substance, the method comprising the steps of: coupling a frequency meter to a sensor; placing a glass jar over the sensor; connecting an antenna to the sensor; placing the antenna proximal to the jar; shielding the entire set-up from any ambient external EM fields; taking a first measurement to establish a baseline EM field frequency; placing a quantity of the substance in the glass jar; taking a second measurement to establish the combined frequency emitted by the jar and product; and subtracting the first measured frequency from the second measured frequency to determine the frequency emitted by the sample product.
7. A cosmetic or pharmaceutical product adapted to emit EM fields that match the frequency of EM fields emitted by a particular condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood.
8. An electronic device that emits EM fields adapted to match the frequency of EM fields emitted by a particular condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood.
9. A cosmetic or pharmaceutical product adapted to emit EM energy in a frequency, phase and amplitude suitable for treating a condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood.
10. An electronic device adapted to emit EM energy in a frequency, phase and amplitude suitable for treating a condition of a human subject, the condition selected from one of skin rejuvenation, lines and wrinkles, scar and uneven coloration, dark circles, respiratory, cardiovascular, neurological, gastrointestinal, tumorigenic, musculoskeletal, diabetic, tinnitus and mood.
PCT/US2009/057570 2008-09-23 2009-09-18 Methods of measuring human body frequencies or harmonics and treating conditions based on the resonance phenomenon between a product and a human body's frequencies or harmonics WO2010039465A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US9926208P true 2008-09-23 2008-09-23
US61/099,262 2008-09-23

Publications (2)

Publication Number Publication Date
WO2010039465A2 true WO2010039465A2 (en) 2010-04-08
WO2010039465A3 WO2010039465A3 (en) 2010-07-22

Family

ID=42074098

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/057570 WO2010039465A2 (en) 2008-09-23 2009-09-18 Methods of measuring human body frequencies or harmonics and treating conditions based on the resonance phenomenon between a product and a human body's frequencies or harmonics

Country Status (1)

Country Link
WO (1) WO2010039465A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192429B2 (en) 2010-06-29 2012-06-05 Theravant, Inc. Abnormality eradication through resonance
WO2017127739A1 (en) * 2016-01-20 2017-07-27 Soniphi Llc Frequency analysis feedback systems and methods
IT201600112285A1 (en) * 2016-11-08 2018-05-08 Tinnitech Ltd CHEMICAL-PHYSICAL SYSTEM FOR THE TREATMENT OF ACUFENI

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6633779B1 (en) * 2000-11-27 2003-10-14 Science Medicus, Inc. Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms
US20050158285A1 (en) * 2003-12-09 2005-07-21 Giampapa Vincent C. Method of re-profiling adult stem cells using embryonic stem cell electromagnetic signals
US6949071B1 (en) * 1998-01-12 2005-09-27 Centre National De La Recherche Scientifique Method for exploring and displaying tissue of human or animal origin from a high frequency ultrasound probe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949071B1 (en) * 1998-01-12 2005-09-27 Centre National De La Recherche Scientifique Method for exploring and displaying tissue of human or animal origin from a high frequency ultrasound probe
US6633779B1 (en) * 2000-11-27 2003-10-14 Science Medicus, Inc. Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms
US20050158285A1 (en) * 2003-12-09 2005-07-21 Giampapa Vincent C. Method of re-profiling adult stem cells using embryonic stem cell electromagnetic signals

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192429B2 (en) 2010-06-29 2012-06-05 Theravant, Inc. Abnormality eradication through resonance
WO2017127739A1 (en) * 2016-01-20 2017-07-27 Soniphi Llc Frequency analysis feedback systems and methods
CN108882851A (en) * 2016-01-20 2018-11-23 索尼菲有限责任公司 frequency analysis feedback system and method
US10932714B2 (en) 2016-01-20 2021-03-02 Soniphi Llc Frequency analysis feedback systems and methods
IT201600112285A1 (en) * 2016-11-08 2018-05-08 Tinnitech Ltd CHEMICAL-PHYSICAL SYSTEM FOR THE TREATMENT OF ACUFENI
WO2018087645A1 (en) * 2016-11-08 2018-05-17 Tinnitech Ltd Chemical-physical system for treating tinnitus
US11141081B2 (en) 2016-11-08 2021-10-12 Tinnitech Ltd Chemical-physical system for treating tinnitus

Also Published As

Publication number Publication date
WO2010039465A3 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
Kvernmo et al. Oscillations in the human cutaneous blood perfusion signal modified by endothelium-dependent and endothelium-independent vasodilators
Feldman et al. Human skin as arrays of helical antennas in the millimeter and submillimeter wave range
US7811234B2 (en) Remote-sensing method and device
US20090281422A1 (en) Multi-modality system for imaging in dense compressive media and method of use thereof
Massagram et al. Tidal volume measurement through non-contact Doppler radar with DC reconstruction
US20070190006A1 (en) Methods for measuring moisture as a predictor of scalp health
Yamamoto et al. Characteristics of skin admittance for dry electrodes and the measurement of skin moisturisation
US20070191694A1 (en) Methods for measuring moisture content of skin
WO2010039465A2 (en) Methods of measuring human body frequencies or harmonics and treating conditions based on the resonance phenomenon between a product and a human body's frequencies or harmonics
Oum et al. Two frequency radar sensor for non-contact vital signal monitor
Martinsen et al. Gravimetric method for in vitro calibration of skin hydration measurements
Scalise et al. Non contact monitoring of the respiration activity by electromagnetic sensing.
EP1264576A3 (en) Medical broad band electromagnetic holographic imaging
Dastjerdi et al. Designing and implementing bioimpedance spectroscopy device by measuring impedance in a mouse tissue
JP4343115B2 (en) Biological material and manufacturing method using bioelectromagnetic signal feeling utilizing characteristics and functions of biological epidermal tissue and biological epidermal tissue
Martinsen et al. Line patterns in the mosaic electrical properties of human skin-a cross-correlation study
Qananwah et al. A comparative study of photoplethysmogram and piezoelectric plethysmogram signals
Simonen et al. Normal variation in cutaneous blood content and red blood cell velocity in humans
Obeid et al. Position-free vital sign monitoring: Measurements and processing
Krishnan A SURVEY OF CONTACTLESS
Kukharenko et al. Low power bioimpedance tracking system for stress and activity monitoring
Chen et al. In vivo non-invasive diagnosis of glucose level in type-2 diabetes mouse by THz near-field imaging
Prasanna et al. Multilayer Flexible Substrate Antenna Sensor for PT Measurement From Blood Plasma to Avoid Turbidity and Reagent Sensitivity Variations Through Regression Modelling
CN108273194A (en) Quantum core moxibustion piece
Tavanti et al. A breath monitoring approach based on electrical impedance measurements

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09818233

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09818233

Country of ref document: EP

Kind code of ref document: A2